Last edition
News about "Dr Di Hong"
Nona Biosciences, Link Cell Therapies Partner to Advance Next-Gen CAR-T Antibody Discovery
The multi-target collaboration will combine Nona Biosciences’ fully human HCAb Harbour Mice and NonaCarFx platforms with Link Cell Therapies’ cell therapy expertise to develop novel CAR-T candidates for solid and hematologic cancers.
Dr. Di Hong | 12/01/2026 | By News Bureau
Nona Biosciences Expands Discovery-to-Clinical Capabilities
Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.
Dr Di Hong | 24/12/2025 | By News Bureau
Nona Biosciences and Valink Partner to Advance Biologics Discovery
Nona Biosciences and Valink Therapeutics have partnered to advance biologics discovery by combining Nona’s Harbour Mice fully human antibody technologies, including heavy chain-only antibodies, with Valink’s LiliumX discovery platform to generate and screen thousands of novel drug candidates.
Dr Di Hong | 18/12/2025 | By News Bureau
Nona Biosciences and Umoja Biopharma Expand Partnership to Advance In-vivo CAR-T Therapies
Under the terms of the agreement, Nona Biosciences is eligible to receive an upfront payment, potential option exercise fees and milestone payments tied to the discovery and development of specific programmes in the collaboration. Umoja will be responsible for all further product development and commercialisation.
Dr Di Hong | 07/11/2025 | By Dineshwori | 252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy